期刊文献+

特非那丁对心律失常防治作用的研究 被引量:4

Preventive and therapeutic effects of terfenadine on arrhythmia in guinea pigs
原文传递
导出
摘要 目的 观察特非那丁对豚鼠QT间期(QTc)的影响及其对快速室性心律失常的防治作用。方法(1)腹腔注射特非那丁后观察其对豚鼠QTc的影响。(2)腹腔注射特非那丁后,观察氯化钡诱发快速室性心律失常的难易程度。H时采用胺碘酮作为阳性对照。结果(1)不同浓度的特非那丁在腹腔注射后呈剂量依赖性延长QTc,与生理盐水、DMSO组及给药前比较差异有统计学意义(P〈0.05)。(2)特非那丁可明显缩短3种剂量氯化钡所致室性心动过速(室速)持续的时间。与生理盐水组比较差异有统计学意义(P〈0.05),且特非那丁对氯化钡致室速的防治作用不低于胺碘酮。结论(1)特非那丁可剂量依赖性地延长QTc间期。(2)特非那丁可显著缩短室速持续的时间。 Objective To evaluate the effects of terfenadine on QTc interval and on an experimental ventricular arrhythmia in guinea pigs. Methods ( 1 ) The effect of terfenadine on the QTc interval in guineapigs was evaluated by comparison of multiple ECGs. (2)To induce an experimental arrhythmia, an intraperitoneal injection of BaCl2 was administered. Saline and amiodarone were administered as intraperitoneal injections in separate guinea pigs,which served as controls. Results ( 1 ) In comparison with normal saline and amiodarone, terfenadine caused prolonged QTc interval in the guinea pig that was dose-dependent. (2)In the BaCl2 induced experimental arrhythmia model,terfenadine caused a significant, dose-dependent shortening of the duration of ventricular arrhythmia in comparison with normal saline control ( P 〈0. 05 ). Conclusion The results suggest terfenadine appears to prolong the QTc interval and decrease ventricular arrhythmia duration in a dosedependent manner in guinea pigs.
出处 《中华心律失常学杂志》 2009年第4期279-282,共4页 Chinese Journal of Cardiac Arrhythmias
基金 山西省高校科技研究开发项目基金资助(2006106)
关键词 特非那丁 胺碘酮 豚鼠 QT间期延长 心律失常 Terfenadine Amiodarone Guinea pig QTc interval Arrhythmia
  • 相关文献

参考文献2

二级参考文献27

  • 1华伟,陈新.加强植入型心律转复除颤器的临床应用是面临的迫切任务[J].中华心律失常学杂志,2005,9(1):5-5. 被引量:4
  • 2黄从新.经导管消融治疗心房颤动的现状与展望[J].中华心律失常学杂志,2005,9(2):87-92. 被引量:7
  • 3陈新,黄从新.开展室性早搏的射频导管消融以预防心室颤动[J].中华心律失常学杂志,2005,9(5):325-326. 被引量:20
  • 4王祖禄,梁延春,韩雅玲,孙鸣宇,王晶,马薇,黄从新.标测浦肯野电位和舒张期电位在特发性左心室室性心动过速消融中的作用[J].中华心律失常学杂志,2005,9(5):327-331. 被引量:12
  • 5AVID Investigators. A comparison of antiarrhythmic drugs therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. Antiarrhythmics versus implantable defibrillators (AVID) trial. New Engl J Med, 1997,337 : 1576-1583.
  • 6Kuck KH,Cappato R,Siebels J,et al.Randomized comparison of antiarrhythmic drugs therapy with implantable defibrillators in patients resuscitated from cardiac arrest:The Cardiac Arrest Study-Hamburg,Circulation,2000,102:748-754.
  • 7Smith TW,Cain ME.Class Ⅲ Antiarrhythmic drugs:amiodarone,lbutilide, and sotalol.In Zipes DP,Jalife J eds.Cardiac electrophysiology,from cell to bedside.4th ed.Saunders,2004.89-965.
  • 8Haissaguerre M,Shoda M,Jais P,et al.Mapping and ablation of idiopathic ventricular fibrillation.Circulation,2002,8:962-967.
  • 9Wyse DG,Talajic M,Hafley GE,et al.Antiarrhythmic drugs therapy in the Multicenter Unsustained Tachycardia Trial (MUSTT):drug testing and as re-treated analysis.J Am Call Cardiol,2001,38:344-351.
  • 10Pinter A, Dorian P. Intravenous antiarrhythmic agents. Curr Opin Cardiol,2001,16 : 17-22.

共引文献15

同被引文献57

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部